[3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.

نویسندگان

  • D C Perry
  • J S Rosenbaum
  • M Kurowski
  • W Sadée
چکیده

P. M. LADURON, P. F. M. JANSSEN, W. GOMMEREN, AND J. E. LEYSEN. In Vitro and in Vivo Binding Characteristics of a New Long-Acting Histamine H1 Antagonist, Astemizole 294 J. E. LEYSEN, C. J. E. NIEMEGEERS, J. M. VAN NUETEN, AND P. M. LADURON. [3H] Ketanserin (R 41 468), a Selective 3H-Ligand for Serotonin2 Receptor Binding Sites: Binding Properties, Brain Distribution, and Functional Role 301 T. A. ROBERT, A. N. HAGARDORN, AND E. A. DAIGNEAULT. Differential Stereoselectivity of Methotrimeprazine Enantiomers for Selected Central Nervous System Receptor Types 315

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.

Scatchard analysis of the binding to opioid receptors of [3H]ethylketocyclazocine ([3H]EKC) and [3H]etorphine at equilibrium yielded biphasic plots and computer fitting of the data resulted in a minimal model of two independent saturable binding sites. The KD values for the high- and low-affinity sites were 0.58 and 38 nM for [3H]EKC, and 0.13 and 22 nM for [3H]etorphine. The corresponding dens...

متن کامل

Heterogeneity of opioid receptor binding in brain slices.

A methodological approach was established for the study of ligand binding to multiple opioid receptors in slices from rat brain striatum. Specific binding of radiolabeled opiates was resolved from total binding with enantiomers or excess unlabeled ligand. Equilibrium binding of triated etorphine, dihydromorphine, and ethylketocyclazocine, and competitive displacement of [3H]etorphine and [3H]di...

متن کامل

Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.

Opioid agonists and antagonists can regulate the density of mu-opioid receptors in whole animal and in cell culture. High intrinsic efficacy agonists (e.g., etorphine), but not lower intrinsic efficacy agonists (e.g., morphine), produce mu-opioid receptor down-regulation and can alter the abundance of mu-opioid receptor mRNA. Conversely, opioid antagonists substantially increase the density of ...

متن کامل

Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo.

Chronic opioid agonist treatment produces tolerance and in some cases opioid receptor internalization and down-regulation. Both morphine and etorphine induce tolerance; however, only etorphine produces mu-opioid receptor (muOR) down-regulation. In vitro studies implicate dynamin-2 (DYN-2) and G-protein receptor kinase-2 (GRK-2) in these processes. Therefore, we examined etorphine and morphine e...

متن کامل

Effect of sabcomeline on muscarinic and dopamine receptor binding in intact mouse brain.

Sabcomeline [(R-(Z)-(+)-alpha-(methoxyiamino)-1-azabicyclo[2.2.2]octane-3-acetonitrile)] is a potent and functionally selective muscarinic M1 receptor partial agonist. However, little is known of the binding properties of sabcomeline under in vivo conditions. In this study, muscarinic receptor occupancy by sabcomeline in mouse brain regions and heart was estimated using [3H]quinuclidinyl benzil...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Molecular pharmacology

دوره 21 2  شماره 

صفحات  -

تاریخ انتشار 1982